Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C12H14N4O4S |
| Molecular Weight | 310.329 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=NC=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1OC
InChI
InChIKey=PJSFRIWCGOHTNF-UHFFFAOYSA-N
InChI=1S/C12H14N4O4S/c1-19-10-11(14-7-15-12(10)20-2)16-21(17,18)9-5-3-8(13)4-6-9/h3-7H,13H2,1-2H3,(H,14,15,16)
| Molecular Formula | C12H14N4O4S |
| Molecular Weight | 310.329 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:55:18 UTC 2023
by
admin
on
Sat Dec 16 16:55:18 UTC 2023
|
| Record UNII |
88463U4SM5
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NDF-RT |
N0000008048
Created by
admin on Sat Dec 16 16:55:18 UTC 2023 , Edited by admin on Sat Dec 16 16:55:18 UTC 2023
|
||
|
NDF-RT |
N0000008048
Created by
admin on Sat Dec 16 16:55:18 UTC 2023 , Edited by admin on Sat Dec 16 16:55:18 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
6.5.3.1 (SUL/PYR)
Created by
admin on Sat Dec 16 16:55:18 UTC 2023 , Edited by admin on Sat Dec 16 16:55:18 UTC 2023
|
||
|
WHO-VATC |
QJ01EW13
Created by
admin on Sat Dec 16 16:55:18 UTC 2023 , Edited by admin on Sat Dec 16 16:55:18 UTC 2023
|
||
|
NDF-RT |
N0000175880
Created by
admin on Sat Dec 16 16:55:18 UTC 2023 , Edited by admin on Sat Dec 16 16:55:18 UTC 2023
|
||
|
LIVERTOX |
NBK548044
Created by
admin on Sat Dec 16 16:55:18 UTC 2023 , Edited by admin on Sat Dec 16 16:55:18 UTC 2023
|
||
|
NDF-RT |
N0000008048
Created by
admin on Sat Dec 16 16:55:18 UTC 2023 , Edited by admin on Sat Dec 16 16:55:18 UTC 2023
|
||
|
WHO-VATC |
QJ01EQ13
Created by
admin on Sat Dec 16 16:55:18 UTC 2023 , Edited by admin on Sat Dec 16 16:55:18 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
m10308
Created by
admin on Sat Dec 16 16:55:18 UTC 2023 , Edited by admin on Sat Dec 16 16:55:18 UTC 2023
|
PRIMARY | Merck Index | ||
|
17134
Created by
admin on Sat Dec 16 16:55:18 UTC 2023 , Edited by admin on Sat Dec 16 16:55:18 UTC 2023
|
PRIMARY | |||
|
DB01299
Created by
admin on Sat Dec 16 16:55:18 UTC 2023 , Edited by admin on Sat Dec 16 16:55:18 UTC 2023
|
PRIMARY | |||
|
100000083266
Created by
admin on Sat Dec 16 16:55:18 UTC 2023 , Edited by admin on Sat Dec 16 16:55:18 UTC 2023
|
PRIMARY | |||
|
1626500
Created by
admin on Sat Dec 16 16:55:18 UTC 2023 , Edited by admin on Sat Dec 16 16:55:18 UTC 2023
|
PRIMARY | |||
|
SUB10700MIG
Created by
admin on Sat Dec 16 16:55:18 UTC 2023 , Edited by admin on Sat Dec 16 16:55:18 UTC 2023
|
PRIMARY | |||
|
2503
Created by
admin on Sat Dec 16 16:55:18 UTC 2023 , Edited by admin on Sat Dec 16 16:55:18 UTC 2023
|
PRIMARY | |||
|
219-504-9
Created by
admin on Sat Dec 16 16:55:18 UTC 2023 , Edited by admin on Sat Dec 16 16:55:18 UTC 2023
|
PRIMARY | |||
|
D013413
Created by
admin on Sat Dec 16 16:55:18 UTC 2023 , Edited by admin on Sat Dec 16 16:55:18 UTC 2023
|
PRIMARY | |||
|
SULFADOXINE
Created by
admin on Sat Dec 16 16:55:18 UTC 2023 , Edited by admin on Sat Dec 16 16:55:18 UTC 2023
|
PRIMARY | |||
|
2061
Created by
admin on Sat Dec 16 16:55:18 UTC 2023 , Edited by admin on Sat Dec 16 16:55:18 UTC 2023
|
PRIMARY | |||
|
DTXSID6023608
Created by
admin on Sat Dec 16 16:55:18 UTC 2023 , Edited by admin on Sat Dec 16 16:55:18 UTC 2023
|
PRIMARY | |||
|
759319
Created by
admin on Sat Dec 16 16:55:18 UTC 2023 , Edited by admin on Sat Dec 16 16:55:18 UTC 2023
|
PRIMARY | |||
|
CHEMBL1539
Created by
admin on Sat Dec 16 16:55:18 UTC 2023 , Edited by admin on Sat Dec 16 16:55:18 UTC 2023
|
PRIMARY | |||
|
SULFADOXINE
Created by
admin on Sat Dec 16 16:55:18 UTC 2023 , Edited by admin on Sat Dec 16 16:55:18 UTC 2023
|
PRIMARY | Description: A white or creamy white, crystalline powder; odourless. Solubility: Very slightly soluble in water; slightly soluble in ethanol (~750 g/l) TS and in methanol R; practically insoluble in ether R. Category: Antimalarial drug. Storage: Sulfadoxine should be kept in a well-closed container, protected from light. Definition: Sulfadoxine contains not less than 99.0% and not more than 101.0% of C12H14N4O4S, calculated with reference to the dried substance. | ||
|
9329
Created by
admin on Sat Dec 16 16:55:18 UTC 2023 , Edited by admin on Sat Dec 16 16:55:18 UTC 2023
|
PRIMARY | |||
|
Sulfadoxine and Pyrimethamine
Created by
admin on Sat Dec 16 16:55:18 UTC 2023 , Edited by admin on Sat Dec 16 16:55:18 UTC 2023
|
PRIMARY | |||
|
C47735
Created by
admin on Sat Dec 16 16:55:18 UTC 2023 , Edited by admin on Sat Dec 16 16:55:18 UTC 2023
|
PRIMARY | |||
|
2447-57-6
Created by
admin on Sat Dec 16 16:55:18 UTC 2023 , Edited by admin on Sat Dec 16 16:55:18 UTC 2023
|
PRIMARY | |||
|
10173
Created by
admin on Sat Dec 16 16:55:18 UTC 2023 , Edited by admin on Sat Dec 16 16:55:18 UTC 2023
|
PRIMARY | RxNorm | ||
|
88463U4SM5
Created by
admin on Sat Dec 16 16:55:18 UTC 2023 , Edited by admin on Sat Dec 16 16:55:18 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
BINDER->LIGAND |
BINDING
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Biological Half-life | PHARMACOKINETIC |
|
|
|||